Catalyst Pharmaceuticals Inc (CPRX)
Cost of Revenue
$24.18M
Quarterly · Period ending: · USD
CPRX Cost of Revenue
Latest reported$24.18Mperiod ending
Latest reported$24.18Mperiod ending
CPRX Quarterly Cost of Revenue ($0.00 → $24.18M)
Quarterly cost of revenue
High-resolution chart · PNG
CPRX cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 24,178,000 | |
| 26,074,000 | |
| 25,311,000 | |
| 29,958,000 | |
| 17,911,000 | |
| 21,643,000 | |
| 19,277,000 | |
| 15,405,000 | |
| 12,520,000 | |
| 15,809,000 | |
| 14,167,000 | |
| 12,045,000 | |
| 9,946,000 | |
| 11,195,000 | |
| 9,665,000 | |
| 7,643,000 | |
| 5,890,000 | |
| 7,348,000 | |
| 5,310,000 | |
| 4,545,000 | |
| 4,681,000 | |
| 4,869,658 | |
| 3,879,000 | |
| 4,139,873 | |
| 4,151,000 | |
| 4,398,265 | |
| 4,387,461 | |
| 4,261,625 | |
| 1,711,788 | |
| 8,416,969 | |
| 4,538,369 | |
| 3,704,824 | |
| 3,259,042 | |
| 3,404,634 | |
| 2,704,923 | |
| 2,451,751 | |
| 2,813,929 | |
| 2,820,654 | |
| 2,494,000 | |
| 2,508,897 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |